Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer

dc.contributor.authorFernández Rozadilla, C.
dc.contributor.authorÁlvarez Barona, M.
dc.contributor.authorQuintana, Isabel
dc.contributor.authorLópez Novo, Anael
dc.contributor.authorAmigo, J.
dc.contributor.authorCameselle Teijeiro, J. M.
dc.contributor.authorRoman, E.
dc.contributor.authorGonzález, D.
dc.contributor.authorLlor, Xavier
dc.contributor.authorBujanda, Luis
dc.contributor.authorBessa, X.
dc.contributor.authorJover, R.
dc.contributor.authorBalaguer Prunés, Francesc
dc.contributor.authorCastells Garangou, Antoni
dc.contributor.authorCastellví Bel, Sergi
dc.contributor.authorCapellá, G. (Gabriel)
dc.contributor.authorCarracedo Álvarez, Ángel
dc.contributor.authorValle, Laura
dc.contributor.authorRuiz Ponte, Clara
dc.date.accessioned2021-06-25T10:54:57Z
dc.date.available2021-06-25T10:54:57Z
dc.date.issued2021-05-27
dc.date.updated2021-06-25T08:56:36Z
dc.description.abstractColorectal cancer (CRC) is a complex disease that can be caused by a spectrum of genetic variants ranging from low to high penetrance changes, that interact with the environment to determine which individuals will develop the disease. In this study, we sequenced 20 early-onset CRC patients to discover novel genetic variants that could be linked to the prompt disease development. Eight genes, CHAD, CHD1L, ERCC6, IGTB7, PTPN13, SPATA20, TDG and TGS1, were selected and re-sequenced in a further 304 early onset CRC patients to search for rare, high-impact variants. Although we found a recurring truncating variant in the TDG gene shared by two independent patients, the results obtained did not help consolidate any of the candidates as promising CRC predisposing genes. However, we found that potential risk alleles in our extended list of candidate variants have a tendency to appear at higher numbers in younger cases. This supports the idea that CRC onset may be oligogenic in nature and may show molecular heterogeneity. Further, larger and robust studies are thus needed to unravel the genetics behind early-onset CRC development, coupled with novel functional analyses and omic approaches that may offer complementary insight.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec713400
dc.identifier.pmid34045552
dc.identifier.urihttps://hdl.handle.net/2445/178672
dc.language.isoeng
dc.publisherSpringer Nature
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41598-021-90590-z
dc.relation.ispartofScientific Reports, 2021, vol. 11
dc.relation.urihttps://doi.org/10.1038/s41598-021-90590-z
dc.rightscc by (c) Fernández Rozadilla et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationCàncer colorectal
dc.subject.classificationGenètica
dc.subject.otherColorectal cancer
dc.subject.otherGenetics
dc.titleExome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
s41598-021-90590-z.pdf
Mida:
974.53 KB
Format:
Adobe Portable Document Format